Literature DB >> 22210971

Semiparametric Bayesian approaches to joinpoint regression for population-based cancer survival data.

Pulak Ghosh1, Lan Huang, Binbing Yu, Ram C Tiwari.   

Abstract

According to the American Cancer Society report (1999), cancer surpasses heart disease as the leading cause of death in the United States of America (USA) for people of age less than 85. Thus, medical research in cancer is an important public health interest. Understanding how medical improvements are affecting cancer incidence, mortality and survival is critical for effective cancer control. In this paper, we study the cancer survival trend on the population level cancer data. In particular, we develop a parametric Bayesian joinpoint regression model based on a Poisson distribution for the relative survival. To avoid identifying the cause of death, we only conduct analysis based on the relative survival. The method is further extended to the semiparametric Bayesian joinpoint regression models wherein the parametric distributional assumptions of the joinpoint regression models are relaxed by modeling the distribution of regression slopes using Dirichlet process mixtures. We also consider the effect of adding covariates of interest in the joinpoint model. Three model selection criteria, namely, the conditional predictive ordinate (CPO), the expected predictive deviance (EPD), and the deviance information criteria (DIC), are used to select the number of joinpoints. We analyze the grouped survival data for distant testicular cancer from the Surveillance, Epidemiology, and End Results (SEER) Program using these Bayesian models.

Entities:  

Year:  2009        PMID: 22210971      PMCID: PMC3247916          DOI: 10.1016/j.csda.2009.04.011

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   1.681


  12 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  A review and critique of some models used in competing risk analysis.

Authors:  M Gail
Journal:  Biometrics       Date:  1975-03       Impact factor: 2.571

3.  Statistical smoothing of neuronal data.

Authors:  Robert E Kass; Valérie Ventura; Can Cai
Journal:  Network       Date:  2003-02       Impact factor: 1.273

4.  The relative survival rate: a statistical methodology.

Authors:  F EDERER; L M AXTELL; S J CUTLER
Journal:  Natl Cancer Inst Monogr       Date:  1961-09

5.  A semi-parametric Bayesian approach to average bioequivalence.

Authors:  Pulak Ghosh; Gary L Rosner
Journal:  Stat Med       Date:  2007-03-15       Impact factor: 2.373

6.  Diamminodichloroplatinum in the chemotherapy of testicular tumors.

Authors:  D J Higby; H J Wallace; D Albert; J F Holland
Journal:  J Urol       Date:  1974-07       Impact factor: 7.450

7.  Piecewise exponential survival curves with smooth transitions.

Authors:  D Zelterman; P M Grambsch; C T Le; J Z Ma; J W Curtsinger
Journal:  Math Biosci       Date:  1994-04       Impact factor: 2.144

8.  The impact of breakthrough clinical trials on survival in population based tumor registries.

Authors:  E J Feuer; L G Kessler; S G Baker; H E Triolo; D T Green
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

9.  Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.

Authors:  K A Cronin; E J Feuer
Journal:  Stat Med       Date:  2000-07-15       Impact factor: 2.373

10.  Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons.

Authors:  D I Ohlssen; L D Sharples; D J Spiegelhalter
Journal:  Stat Med       Date:  2007-04-30       Impact factor: 2.373

View more
  1 in total

1.  Predicting county-level cancer incidence rates and counts in the USA.

Authors:  Binbing Yu
Journal:  Stat Med       Date:  2013-05-13       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.